ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
About N/A of shares are held by financial institutions. B. RILEY WEALTH ADVISORS, INC. is the top corporate investor, holding 12.73K shares valued at $16.23K. A 0.03% stake in Zynerba Pharmaceuticals, Inc. is owned by the company. FIFTH LANE CAPITAL, LP owns 100K shares valued at $127.00K, which translates its holding of 0.2% of the stake in the company.
Among the ZYNE insiders holding of N/A of the stake in company, RAPP MICHAEL, 10 percent owner, holds the largest shares of 1.5M. ANIDO ARMANDO, Chairman & Chief Exec. Officer, is the second largest ZYNE insider with ownership of 936.72K shares. SEBREE TERRI B, President, stands third with possession of 596.24K shares of that stake.